Status:
COMPLETED
Hepatitis B Birth Dose for Newborns
Lead Sponsor:
Quaid-e-Azam University
Collaborating Sponsors:
Medical Research Council, Pakistan
Health Services Academy, Islamabad, Pakistan
Conditions:
Hepatitis B
Immunization; Infection
Eligibility:
All Genders
12-8 years
Phase:
PHASE4
Brief Summary
With 2.5% prevalence in general population, Pakistan is an intermediate endemicity country for hepatitis B. However, wide disparity exists across the country as disease prevalence in general populatio...
Detailed Description
Study Design: The study is an unblinded, open-labeled, non-inferiority, randomized controlled trial with a participant ratio of 1:1 in each group (the design remained the same through the length of t...
Eligibility Criteria
Inclusion
- Newborn with weight more than 2000 grams
- Born to health mothers
- No sign of congenital disease
Exclusion
- Low birth weight newborn
- Signs and Symptoms of febrile Illness/sepsis
- Congenital Malformation
- Signs of Cyanosis
- Difficulty in breathing
Key Trial Info
Start Date :
March 15 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2016
Estimated Enrollment :
218 Patients enrolled
Trial Details
Trial ID
NCT04870021
Start Date
March 15 2015
End Date
June 30 2016
Last Update
May 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Countess Dufferin Fund (CDF) Hospital
Hyderābād, Pakistan